Mayo Clinic
The firm said it is actively forging partnerships in the clinical and applied industrial markets to drive adoption of its nanopore sequencing products.
Oxford Nanopore Nabs £70M Investment From BioMérieux, Signs Clinical Collaboration With Mayo Clinic
The investment comes after Oxford Nanopore and BioMérieux's collaboration agreement earlier this year for the development of infectious disease diagnostics.
ProPhase Labs Partners With mProbe, Mayo Clinic on Esophageal Cancer Screening Test
The mass spec-based proteomic assay, which was originally developed by Stella Diagnostics, is designed for the early detection of esophageal cancer.
In Brief This Week: Thermo Fisher Scientific, Leica Biosystems, Genetron, SomaLogic, More
News items for the week of Nov. 7, 2022.
Genomadix, Mayo Clinic Collaborate on Point-of-Care PCR
The deal is intended to advance the firm's portable PCR-based diagnostics system, called the Cube, which generates results in approximately one hour.
Jul 24, 2022
Apr 13, 2022
Jun 2, 2021